|
| 36127823 | Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. | Cancer Med | 2023 |
| 37397388 | A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study. | Front Oncol | 2023 |
| 36996147 | Quantitative determination of lurbinectedin, its unbound fraction and its metabolites in human plasma utilizing ultra-performance LC-MS/MS. | PLoS One | 2023 |
| 34739582 | Integrated exposure-response analysis of efficacy and safety of lurbinectedin to support the dose regimen in small-cell lung cancer. | Cancer Chemother Pharmacol | 2022 |
| 36029310 | Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics. | Cancer Chemother Pharmacol | 2022 |
| 35012962 | Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. | Life Sci Alliance | 2022 |
| 35042701 | Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients. | Drug Metab Dispos | 2022 |
| 34453241 | A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors. | Invest New Drugs | 2022 |
| 33108504 | Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysis. | Cancer Chemother Pharmacol | 2021 |
| 33914350 | Population Pharmacokinetic-Pharmacodynamic Modeling and Covariate Analyses of Neutropenia and Thrombocytopenia in Patients With Solid Tumors Treated With Lurbinectedin. | J Clin Pharmacol | 2021 |
| 34075384 | Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. | medRxiv | 2021 |
| 30411218 | First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors. | Invest New Drugs | 2019 |
| 30090974 | Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer. | Clin Pharmacokinet | 2019 |
| 29883879 | Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of lurbinectedin in human plasma and urine. | J Pharm Biomed Anal | 2018 |
| 29974200 | Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of <sup>14</sup>C-plitidepsin. | Cancer Chemother Pharmacol | 2018 |
| 27977433 | Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas. | Anticancer Drugs | 2017 |
| 28111728 | Pharmacokinetics and excretion of <sup>14</sup>C-Plitidepsin in patients with advanced cancer. | Invest New Drugs | 2017 |
| 28662481 | Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine. | J Pharm Biomed Anal | 2017 |
| 21545624 | Reversible parkinsonism and cognitive decline due to a possible interaction of valproic acid and quetiapine. | J Clin Pharm Ther | 2011 |
| 19840783 | Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram. | Eur J Pharmacol | 2010 |
| 20925644 | Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital. | Curr Clin Pharmacol | 2010 |
| 19890254 | A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients. | Clin Pharmacol Ther | 2010 |
| 19480891 | [Valproate-meropenem co-administration, an example of information shortcomings in relevant drug interactions]. | Med Clin (Barc) | 2009 |
| 18211623 | Sublingual administration of tacrolimus in a renal transplant patient. | J Clin Pharm Ther | 2008 |
| 16882111 | Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. | J Clin Pharm Ther | 2006 |
| 9807854 | [Cortical processing of visual and auditory stimuli in depressive patients: a study with event related potentials]. | Actas Luso Esp Neurol Psiquiatr Cienc Afines | 1998 |